Clinical trial

Diagnostic Performance of PET/CT-PSMA in Patients With Non-prostatic PSMA-expressing Neoplasms

NCT06835244

Study summary

ClinicalTrials.gov

Diagnostic Performance of PET/CT-PSMA in Patients With Non-prostatic PSMA-expressing Neoplasms

Design: OBSERVATIONAL · Status: ENROLLING BY INVITATION · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention 68Ga-PSMA-11 Find medicine records · Find other trials using this name

StatusENROLLING_BY_INVITATION

Study typeOBSERVATIONAL

Start date2021-09-17

PhaseN/A

Conditions

PSMA Positive Tumors or Tumor Tissuesunresolved

Cancerverified · MONDO: cancer

Interventions

68Ga-PSMA-11OTHER

Sponsors & collaborators

IRCCS Azienda Ospedaliero-Universitaria di Bolognalead sponsor

Mapped research locations

BolognaItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06835244 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.